One of the largest breast implant manufacturers, Allergan, has issued a global recall of its Biocell product line of textured breast implants at the request of the U.S. Food and Drugs Administration (FDA).
Major repercussions in the overall breast implant market will follow the voluntary recall of Allergan’s Biocell products.
Biocell implants are saline and silicone-filled breast implants that are textured, allowing the implant to attach to the breast tissue and creating a fuller, more natural-looking tear drop shape to the breast.
